XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019   $ 1 $ 370,142 $ (819) $ (357,627) $ 11,697
Balance (in shares) at Dec. 31, 2019 335,537 859,998        
Stock-based compensation     90     90
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (11,187)   (11,187)
Translation adjustment       11,060   11,060
Loss for the period         (1,220) (1,220)
Balance at Mar. 31, 2020   $ 1 370,182 (946) (358,847) 10,390
Balance (in shares) at Mar. 31, 2020 335,537 859,998        
Balance at Dec. 31, 2019   $ 1 370,142 (819) (357,627) 11,697
Balance (in shares) at Dec. 31, 2019 335,537 859,998        
Unrealized foreign exchange on intercompany loans           (11,884)
Translation adjustment           11,769
Loss for the period           (3,386)
Balance at Jun. 30, 2020   $ 5 388,520 (934) (361,013) 26,578
Balance (in shares) at Jun. 30, 2020 335,537 4,863,984        
Balance at Mar. 31, 2020   $ 1 370,182 (946) (358,847) 10,390
Balance (in shares) at Mar. 31, 2020 335,537 859,998        
Issue of common stock, pre-funded warrants and warrants on equity financing, net of expenses   $ 4 18,302     18,306
Issue of common stock, pre-funded warrants and warrants on equity financing, net of expenses (in shares)   4,003,986        
Stock-based compensation     86     86
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       (697)   (697)
Translation adjustment       709   709
Loss for the period         (2,166) (2,166)
Balance at Jun. 30, 2020   $ 5 388,520 (934) (361,013) 26,578
Balance (in shares) at Jun. 30, 2020 335,537 4,863,984        
Balance at Dec. 31, 2020   $ 6 400,071 (746) (366,072) 33,259
Balance (in shares) at Dec. 31, 2020 573,282 6,246,896        
Issuance of common stock in underwritten offering, net of issuance costs   $ 2 13,500     13,502
Issuance of common stock in underwritten offering, net of issuance costs (in shares)   2,078,214        
Warrant exercises   $ 1 4,544     4,545
Warrant exercises (in shares)   909,000        
Stock-based compensation     255     255
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       1,599   1,599
Translation adjustment       (1,583)   (1,583)
Loss for the period         (3,478) (3,478)
Balance at Mar. 31, 2021   $ 9 418,320 (730) (369,550) 48,049
Balance (in shares) at Mar. 31, 2021 573,282 9,234,110        
Balance at Dec. 31, 2020   $ 6 400,071 (746) (366,072) 33,259
Balance (in shares) at Dec. 31, 2020 573,282 6,246,896        
Unrealized foreign exchange on intercompany loans           2,540
Translation adjustment           (2,452)
Loss for the period           (8,605)
Balance at Jun. 30, 2021   $ 9 418,542 (658) (374,677) 43,216
Balance (in shares) at Jun. 30, 2021 573,282 9,234,110        
Balance at Mar. 31, 2021   $ 9 418,320 (730) (369,550) 48,049
Balance (in shares) at Mar. 31, 2021 573,282 9,234,110        
Stock-based compensation     272     272
Preferred stock dividends     (50)     (50)
Unrealized foreign exchange on intercompany loans       941   941
Translation adjustment       (869)   (869)
Loss for the period         (5,127) (5,127)
Balance at Jun. 30, 2021   $ 9 $ 418,542 $ (658) $ (374,677) $ 43,216
Balance (in shares) at Jun. 30, 2021 573,282 9,234,110